Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction

BACKGROUND: Right ventricular (RV) dysfunction predicts adverse outcome in peripartum cardiomyopathy (PPCM). We recently demonstrated beneficial effects associated with the prolactin release inhibitor bromocriptine at different doses when added to standard heart failure therapy in PPCM. Here, we eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Haghikia, Arash, Schwab, Johannes, Vogel-Claussen, Jens, Berliner, Dominik, Pfeffer, Tobias, König, Tobias, Zwadlo, Carolin, Moulig, Valeska Abou, Franke, Annegret, Schwarzkopf, Marziel, Ehlermann, Philipp, Pfister, Roman, Michels, Guido, Westenfeld, Ralf, Stangl, Verena, Kühl, Uwe, Podewski, Edith, Kindermann, Ingrid, Böhm, Michael, Sliwa, Karen, Hilfiker-Kleiner, Denise, Bauersachs, Johann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394477/
https://www.ncbi.nlm.nih.gov/pubmed/30121697
http://dx.doi.org/10.1007/s00392-018-1355-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394477/
https://www.ncbi.nlm.nih.gov/pubmed/30121697
http://dx.doi.org/10.1007/s00392-018-1355-7

Ejemplares similares